|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Supplementa- tion with N-acetyleysteine and taurine failed to restore glutathi- one content in liver of streptozotocin-induced diabetics rats but protected from oxidative stress 显示文摘 | Patriarca S Furfaro AL Domenicotti C | 2005 | Biochim Biophys Acta2005，1741，12： | 1 |
| 2 | Epithelial cell adhesion molecule expression(CD326)in cancer:a short review显示文摘 | Patriarca C Macchi RM Marschner AK | 2012 | Cancer Treat Rev2012，38，1： | 1 |
| 3 | Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation 显示文摘 | Patriarca F Prosdocimo S Tomadini V | 2005 | Haematology2005，90，2： | 1 |
| 4 | Recent Developments in Trace Element Analysis in the Prevention, Diagnosis, and Treatment of Diseases显示文摘 | Patriarca M Menditto A DiFelice G | 1998 | Microchemical Journal1998，59，： | 1 |
| 5 | Occurrence of multiple myeloma after fludarabine treatment of a chronic lymphocytic leukemia: evidence of a biclonal derivation and clinical response to autologous stem cell transplantation 显示文摘 | Patriarca F Gaidano G Capello D | 2000 | Haematologica2000，85，9： | 1 |
| 6 | Sclerodermatous chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation:incidence,predictors and outcome显示文摘 | Skert C Patriarca F Sperotto A | 2006 | Haematologica2006，91，2： | 1 |
| 7 | A comparison of allografting with au- tografting for newly diagnosed myeloma显示文摘 | Bruno B Rotta M Patriarca F | 2007 | N Engl J Med2007，356，11： | 1 |
| 8 | Bortezomib with thalidomide plus dexamethasone compared with thalido- mide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem- cell transplantation in newly diagnosed multiple myelo- ma:a randomised phase 3 study 显示文摘 | Cavo M Tacchetti P Patriarca F | 2010 | Lancet2010，376，9758： | 1 |
| 9 | Control of embryonic stem cell metastability by L-proline catabolism显示文摘The molecular mechanisms controlling mouse embryonic stem cell(ESC)metastability,i.e.their capacity to fluctuate between different states of pluripotency,are not fully resolved.We developed and used a novel automation platform,the Cellmaker,to screen a library of metabolites on two ESC-based phenotypic assays(i.e.proliferation and colony phenotype)and identified two metabolically related amino acids,namely L-proline(L-Pro)and L-ornithine(L-Orn),as key regulators of ESC metastability.Both compounds,but mainly L-Pro,force ESCs toward a novel epiblast stem cell(EpiSC)-like state,in a dose-and time-dependent manner.Unlike EpiSCs,L-Pro-induced cells(PiCs)contribute to chimeric embryos and rely on leukemia inhibitor factor(LIF)to self-renew.Furthermore,PiCs revert to ESCs or differentiate randomly upon removal of either L-Pro or LIF,respectively.Remarkably,PiC generation depends on both L-Pro metabolism(uptake and oxidation)and Fgf5 induction,and is strongly counteracted by antioxidants,mainly L-ascorbic acid(vitamin C,Vc).ESCs↔PiCs phenotypic transition thus represents a previously undefined dynamic equilibrium between pluripotent states,which can be unbalanced either toward an EpiSC-like or an ESC phenotype by L-Pro/L-Orn or Vc treatments,respectively.All together,our data provide evidence that ESC metastability can be regulated at a metabolic level. | Laura Casalino Stefania Comes Giuseppina Lambazzi Benedetta De Stefano Stefania Filosa Sandro De Falco Dario De Cesare Gabriella Minchiotti Eduardo Jorge Patriarca | 2011 | Journal of Molecular Cell Biology2011，3，2： | 1 |
| 10 | Rush desensitization in heparin hypersensitivity: a case report显示文摘 | Patriarca G Rossi M Schiavino D | 2002 | Allergy2002，49，4： | 1 |
| 11 | Transvaginal sonographic tubal patency testing using air and saline solulion as contrast media in a routine infertility clinic setting显示文摘 | Volpi E Zuccaro G Patriarca A | 1996 | Ultrasound Obstet Gynecd1996，7，1： | 1 |
| 12 | Evidence that elastase is the TNF-R75 shedding enzyme in resting human polyrner-phonuclear leukocytes显示文摘 | Gasparini C Menegazzi R Patriarca Pv | 2003 | FEBS Lett2003，553，3： | 1 |
| 13 | Incidence, outcome, and risk factors of /ate-onset noninfectious pulmonary,- complications after unrelated donor stem cell transplanta- tion显示文摘 | Patriarca F Skert C Sperotto A | 2004 | Bone Marrow Transplant2004，33，7： | 1 |
| 14 | Adhesion molecules and tumor metastasis 显示文摘 | Koukoulis GK Patriarca C Gould VE | 1998 | Hum Pathol1998，29，9： | 1 |
| 15 | Clinical prese-ntation,outcome and risk factors of late-onset noninfectious pulmonary complications after allogeneic stem cell transplant-ation显示文摘 | Patriarca F Poletti V Costabel U | 2009 | Curr Stem Cell Res Ther2009，4，2： | 1 |
| 16 | Pretransplantation fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation显示文摘 | Dodero A Crocchiolo R Patriarca F | 2010 | Cancer2010，116，21： | 1 |
| 17 | A comparison of allografting with antografting in myeloma显示文摘 | Bruno B Rotta M Patriarca F | 2007 | N Engl J Med2007，356，： | 1 |
| 18 | ASA disease: the clinical relationship of nasal polyposis to ASA intolerance显示文摘 | Dr. G. Patriarca A. Romano D. Schiavino A. Venuti V. Rienzo G. Fais E. Nucera | 1986 | Archives of Oto - Rhino - Laryngology1986，，1： | 1 |
| 19 | Ultrasonic monitoring as a method of preventing risks of ovarian hyperstimulation during drug therapy显示文摘 | Grio R Patriarca A Ramo ndini L | 1999 | Minerva Gineeol1999，51，12： | 1 |
| 20 | Clinical presentation, outcome and risk factors of late - onset non - infectious pulmonary complications ',ffter allogeneic stem cell transplantation 显示文摘 | Patriarca F Poletti V Costabel U | 2009 | Curt Stem Cell Res Ther2009，4，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员